Literature DB >> 32796099

Non-EPI-DWI for Detection, Disease Monitoring, and Clinical Decision-Making in Thyroid Eye Disease.

C Feeney1,2, R K Lingam3, V Lee4, F Rahman1, S Nagendran1.   

Abstract

BACKGROUND AND
PURPOSE: The Clinical Activity Score is widely used to grade activity of thyroid eye disease and guide treatment decisions, but as a subjective measurement and being confined to the anterior orbit, it has limitations. Non-EPI-DWI of the extraocular muscles may offer advantages as a functional imaging technique with reduced skull base artifacts, but the correlation with the Clinical Activity Score and patient outcome is unknown. Our aim was to establish the correlation between the Clinical Activity Score and non-EPI-DWI and to describe the additional value provided by adjunctive non-EPI-DWI in making clinical decisions.
MATERIALS AND METHODS: This was a retrospective longitudinal study of 31 patients seen in a multidisciplinary thyroid eye disease clinic during 5 years who had at least 1 ophthalmic and endocrine assessment including the Clinical Activity Score and a non-EPI-DWI ADC calculation. The Spearman rank correlation coefficient was used to determine the relationship between the Clinical Activity Score and non-EPI-DWI. A patient flow chart was constructed to evaluate clinical decision-making, and receiver operating characteristics were generated.
RESULTS: From 60 non-EPI-DWI scans, 368 extraocular muscles were selected for analysis. There was a significant positive correlation between the Clinical Activity Score and ADC (r s = 0.403; 95% CI, 0.312-0.489; P < .001). ADC values were significantly higher in the Clinical Activity Score ≥ 3 group compared with the Clinical Activity Score < 3 group (P < .001). Our patient flow chart identified a third intermediate-severity cohort in which the non-EPI-DWI was particularly useful in guiding clinical decisions.
CONCLUSIONS: The non-EPI-DWI correlated well with the Clinical Activity Score in our patients and was a useful adjunct to the Clinical Activity Score in making clinical decisions, especially in patients with intermediate activity and severity of thyroid eye disease.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 32796099      PMCID: PMC7658861          DOI: 10.3174/ajnr.A6664

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Management of exophthalmos and related ocular changes in Graves' disease.

Authors:  F F RUNDLE
Journal:  Metabolism       Date:  1957-01       Impact factor: 8.694

Review 2.  Neuroimaging of Graves' orbitopathy.

Authors:  Wibke Müller-Forell; George J Kahaly
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

3.  A Meta-Analysis on the Diagnostic Performance of Non-Echoplanar Diffusion-Weighted Imaging in Detecting Middle Ear Cholesteatoma: 10 Years On.

Authors:  Ravi K Lingam; Paul Bassett
Journal:  Otol Neurotol       Date:  2017-04       Impact factor: 2.311

4.  Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy.

Authors:  Ahmed Ak Abdel Razek; Mohamed El-Hadidy; Mohamed E Moawad; Nader El-Metwaly; Amr A El-Said
Journal:  Neuroradiol J       Date:  2017-04-05

Review 5.  Grading Severity and Activity in Thyroid Eye Disease.

Authors:  Peter J Dolman
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 1.746

6.  Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study.

Authors:  Ravi Kumar Lingam; Pravin Mundada; Vickie Lee
Journal:  Orbit       Date:  2018-01-10

Review 7.  Imaging of postoperative middle ear cholesteatoma.

Authors:  S Khemani; A Singh; R K Lingam; A Kalan
Journal:  Clin Radiol       Date:  2011-04-23       Impact factor: 2.350

Review 8.  Pathogenesis of Graves' orbitopathy: a 2010 update.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

9.  Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.

Authors:  M L Tanda; E Piantanida; L Liparulo; G Veronesi; A Lai; L Sassi; N Pariani; D Gallo; C Azzolini; M Ferrario; L Bartalena
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

10.  Using Non-Echoplanar Diffusion Weighted MRI in Detecting Cholesteatoma Following Canal Wall Down Mastoidectomy - Our Experience with 20 Patient Episodes.

Authors:  Bhavesh Patel; Andrew Hall; Ravi Lingam; Arvind Singh
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

View more
  6 in total

1.  Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper.

Authors:  Felice D'Arco; Livja Mertiri; Pim de Graaf; Bert De Foer; Katarina S Popovič; Maria I Argyropoulou; Kshitij Mankad; Hervé J Brisse; Amy Juliano; Mariasavina Severino; Sofie Van Cauter; Mai-Lan Ho; Caroline D Robson; Ata Siddiqui; Steve Connor; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2022-04-23       Impact factor: 2.804

Review 2.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

3.  A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.

Authors:  Soma Farag; Claire Feeney; Vickie Lee; Sonali Nagendran; Rajni Jain; Ahmad Aziz; Rashmi Akishar; Vassiliki Bravis; Karim Meeran
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

4.  Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease.

Authors:  Nicole Quah Qin Xian; Ahmed Alnahrawy; Rashmi Akshikar; Vickie Lee
Journal:  Clin Ophthalmol       Date:  2021-05-10

5.  Diffusion Tensor Imaging Technology to Quantitatively Assess Abnormal Changes in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Li Rui; Li Jing; Wang Zhenchang
Journal:  Front Hum Neurosci       Date:  2022-02-04       Impact factor: 3.169

6.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.